MedPath

Engaging Practices and Communities in the Development of Interventions to Promote HPV Vaccine Uptake

Not Applicable
Recruiting
Conditions
Primary Prevention
Interventions
Other: Control
Behavioral: Boot Camp Translation
Registration Number
NCT04279964
Lead Sponsor
University of Colorado, Denver
Brief Summary

The overarching goal of this project is to implement Boot Camp Translation (BCT) methodology to translate the guidelines and evidence for human papillomavirus (HPV) vaccine into a practice and provider level intervention designed to improve its acceptability and uptake.

Detailed Description

As a community engagement approach, Boot Camp Translation (BCT), is a 6-9-month iterative process that brings together multiple stakeholders, including patients, parents, and community members, to translate evidence-based guidelines and recommendations into locally relevant and meaningful messages, materials, and programs.

Aim 1: Implement BCT in three geographically distinct Colorado communities to translate the current evidence for HPV vaccination into locally relevant interventions designed to increase vaccine uptake.

Aim 2: Evaluate the impact of the BCT- designed intervention on practice-level HPV vaccination initiation rates.

The long-term goal is to develop a replicable approach and low-cost method of increasing HPV vaccine uptake that is easily adaptable to different settings and sociodemographic contexts.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5000
Inclusion Criteria

All child patients who have received health supervision at participating practices during the 12 month prior to intervention and the 12 month following intervention implementation, who are ages 9-26 years, and whose parents have not requested removal from the Colorado Immunization Information System (CIIS) will be eligible for the assessment of practice immunization rates in the pre and post periods.

Read More
Exclusion Criteria
  • No subjects will be excluded because of gender, ethnicity, or insurance status.
  • Any child whose parents have requested removal from the immunization registry; any child with hypersensitivity to any component of one of the recommended vaccines; any child who has moved to a primary care provider other than one at the study clinics.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlControlControl practice will behave as usual.
Boot Camp TranslationBoot Camp TranslationIntervention practices will undergo the Boot Camp Translation process.
Primary Outcome Measures
NameTimeMethod
Initiation of HPV vaccination series, 9-17Up to 12 months

Percent of 9-17 year olds who have received \>=1 dose of the HPV vaccine by September 29, 2021

Secondary Outcome Measures
NameTimeMethod
Differences in initiation rates between intervention vs. control, 11-1212 months

Comparison of boys vs. girls who have received \>1=dose of HPV vaccine by September 29, 2021

Differences in initiation rates between intervention vs. control, 9-1012 months

Comparison of boys vs. girls who have received \>1=dose of HPV vaccine by September 29, 2021

Differences in initiation rates between intervention vs. control, 13-1712 months

Comparison of boys vs. girls who have received \>1=dose of HPV vaccine by September 29, 2021

Differences in initiation rates between intervention vs. control, 18-2612 months

Percent of 18-26 year olds who have received \>=1 dose of the HPV vaccine by September 29, 2021

Trial Locations

Locations (1)

University of Colorado Hospital

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath